1. 240 DYSPLASIAS REVISITED – CONSIDERATIONS FOR A MULTIDIMENSIONAL APPROACH TO HETEROGENEITY OF MDS: DATA ON 1979 PATIENTS FROM THE GERMAN AUSTRIAN DATA BASE. Issue 1 (April 2015) Authors: Pfeilstöcker, M.; Tuechler, H.; Nachtkamp, K.; Platzbecker, U.; Schönmetzler, A.; Sperr, W.; Stauder, R.; Strupp, C.; Valent, P.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 318 THE IPSS-R HAS PROGNOSTIC IMPACT IN UNTREATED PATIENTS WITH MDS DEL(5Q). Issue 1 (April 2015) Authors: Schemenau, J.; Lauseker, M.; Hildebrandt, B.; Fenaux, P.; Pfeilstöcker, M.; Valent, P.; Platzbecker, U.; Kündgen, A.; Bug, G.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The IPSS-R has prognostic impact in untreated patients with MDS del(5q). (September 2018) Authors: Kaivers, J.; Lauseker, M.; Hildebrandt, B.; Fenaux, P.; Pfeilstöcker, M.; Valent, P.; Platzbecker, U.; Latagliata, R.; Oliva, E.N.; Xicoy, B.; Götze, K.; Ganster, C.; Haase, D.; Bug, G.; Kündgen, A.; Gattermann, N.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 72(2018) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Topic: AS02-Epidemiology: COMPARISON OF CYTOGENETIC ABERRATIONS IN 1590 PATIENTS WITH THERAPY-RELATED MDS (T-MDS) AND 4738 PATIENTS FROM THE REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM DATABASE WITH PRIMARY-MDS (P-MDS). (September 2021) Authors: Kuendgen, A.; Nomdedeu, M.; Tuechler, H.; Garcia-Manero, G.; Komrokji, R.; Sekeres, M.; Della Porta, M.; Cazzola, M.; Malcovati, L.; Dezern, A.; Roboz, G.; Steensma, D.; Haase, D.; Stauder, R.; Cedena, M.T.; Van De Loosdrecht, A.; Schlenk, R.; Blum, S.; Grau, J.; Calvo, X. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: A STEP TOWARDS IDENTIFICATION AND CAUSAL INTERPRETATION OF THERAPY-RELATED MDS (T-MDS). (May 2023) Authors: Kuendgen, A.; Nomdedeu, M.; Tuechler, H.; Garcia-Manero, G.; Komrokji, R.; Sekeres, M.; Della Porta, M.; Cazzola, M.; Dezern, A.; Roboz, G.; Steensma, D.; Van De Loosdrecht, A.; Malcovati, L.; Schlenk, R.; Grau, J.; Calvo, X.; Blum, S.; Pereira, A.; Valent, P.; Costa, D. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: ACCELERATED FAILURE TIME MODELS AS A CLINICALLY PLAUSIBLE WAY TO DESCRIBE SURVIVAL IN MDS – AN ANALYSIS OF THE IWG-PM DATABASE. (May 2023) Authors: Pfeilstöcker, M.; Tuechler, H.; Ades, L.; Cermak, J.; Chermat, F.; Della Porta, M.; Fenaux, P.; Garcia-Manero, G.; Germing, U.; Haase, D.; Kündgen, A.; Lübbert, M.; Magalhaes, S.; Malcovati, L.; Miyazaki, Y.; Sanz, G.; Santini, V.; Sekeres, M.; Walter, M.; Valent, P. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: IMPROVED PROGNOSIS OF PATIENTS WITH MDS OVER FOUR DECADES: ANALYSIS FROM THE GERMAN MDS REGISTRY. (May 2023) Authors: Kasprzak, A.; Strupp, C.; Haase, D.; Ganster, C.; Pfeilstöcker, M.; Blum, S.; Hofmann, W.-K.; Platzbecker, U.; Valent, P.; Beier, F.; Götze, K.; Parmentier, S.; Lübbert, M.; Stauder, R.; Thol, F.; Giagounidis, A.; Tüchler, H.; Lauseker, M.; Gattermann, N.; Kobbe, G. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: INTERMEDIATE RISK KARYOTYPE BY IPSS-R CAN BE SEPARATED INTO 5 PROGNOSTICALLY DISTINCT SUBGROUPS IN MDS PATIENTS. (May 2023) Authors: Nachtkamp, K.; Flatten, V.; Hildebrandt, B.; Kasprzak, A.; Schulz, F.; Strupp, C.; Haase, D.; Ganster, C.; Shirneshan, K.; Rittscher, K.; Götze, K.; Hofmann, W.-K.; Platzbecker, U.; Pfeilstöcker, M.; Valent, P.; Blum, S.; Lübbert, M.; Parmentier, S.; Beier, F.; Sockel, K. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗